Stocks · Health care · Biological Products, (No Diagnostic Substances)

Lexeo Therapeutics, Inc.

LXEO Clue Score11
United States Fiscal year ends December CIK 0001907108 Results filed 12 Aug 2026

What the insiders did Net buying

Insider
Date
Role
Action
Shares
Price
Amount
Richard Nolan Townsend
6 Apr 2026
Chief Executive Officer
Sold on a plan
55,000
$5.69
$313.14K
Richard Nolan Townsend
11 Jul 2024
Chief Executive Officer
Sold on a plan
100
$19.06
$1.91K
Richard Nolan Townsend
11 Jul 2024
Chief Executive Officer
Sold on a plan
27,931
$17.06
$476.50K

What was left out

Form 4 filings counted 98
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 2
Sales on a Rule 10b5-1 plan 3
Sales straight out of an exercise 10
Sales at will 39
Transactions with no price 0
Shares from compensation/vesting 6,496,115
History held since 9 Nov 2023